Activation of these pathways is crucial for tumor establishment and development and lead to specific modulation of HSPGs, such as syndecans-2 and -4 and glypican-1, in addition to other ECM-modulating molecules [36, 37]. This evidence concerns the gene SDC2 and neoplasm.